- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04210102
Community-Acquired Pneumonia Diagnosis Using Lung Ultrasound in Emergency Room Adults (CAPUERA)
February 7, 2020 updated by: Centre Hospitalier Universitaire de Nice
Accuracy of Lung Ultrasound for the Diagnosis of Community-Acquired Pneumonia in Emergency Room Patients
Community-Acquired Pneumonia (CAP) is a major problem in Emergency Department (ED).
Diagnosis relies on combination of clinical symptoms and results of chest radiography (CR).
Patients' management (treatment, support) depends on delay and quality of the diagnosis.
However, signs and symptoms are highly aspecific and interpretation of CR is subject to frequent discrepancies.
Then diagnosis of CAP may be uncertain; therefore, overdiagnosis is frequent and leads to over-use of antimicrobial therapy; missing diagnosis is also deleterious and delays adequate treatment including antibiotics.
CT scan completes CR and helps clinician making properly diagnosis of CAP; obtaining CT in a 4-hour time-lapse allows better diagnosis and management as accurate as an independent expert adjudication committee does.
However availability of CT as well as radiation interrogates on the benefit that Lung Ultrasounds (LUS) may have in diagnosis strategy of suspected CAP.
LUS is a noninvasive easy-to-use device whose practice is widely endorsed worldwide by emergency medicine associations and societies.
Additionally, previous studies advocate for the use of LUS for diagnosis of CAP in the ED.
Therefore the Promotor developed a study to compare LUS and CR as a primary imaging for diagnosis of CAP at the ED.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
234
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: CLAESSENS Yann-Erick, MD, PhD
- Phone Number: +377 97 98 84 42
- Email: yann-erick.claessens@chpg.mc
Study Contact Backup
- Name: LABIT Melody
- Phone Number: +377 97 98 84 42
- Email: recherche.clinique@chpg.mc
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Adult patients (18+)
- Suspected CAP by attending emergency physician
- And new onset of systemic infection (at least one among sweat, chills, aches and pain, temperature ≥38°C or <36°C)
- And symptoms of an acute lower respiratory tract infection (at least one among cough, sputum production, dyspnea, chest pain, altered breathing sounds at auscultation
- No previous imaging for the current medical problem
- Inform consent (signed)
- Affiliation to insurance (France, Monaco)
Exclusion Criteria:
- Age below 18-year of age
- Patients in palliative care
- Pregnant women
- anticipated barriers to completing follow-up data collection,
- patients classified three or higher according to the CRB65 score,
- patients requiring intensive care for any purpose because of specific management of critically ill
- refusal to participate to the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: DIAGNOSTIC
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
OTHER: CR + LUS
Patient will be performed first the Chest radiography then the Lung ultrasound.
|
Lung Ultrasound : Ultrasound is a medical imaging technique that relies on the use of ultrasound, inaudible sound waves, which allow to "visualize" lungs.
The chest X-ray is a medical imaging examination that provides images of the lungs through the X-ray pulse.
|
OTHER: LUS + CR
Patient will be performed first the Lung ultrasound then the Chest radiography
|
Lung Ultrasound : Ultrasound is a medical imaging technique that relies on the use of ultrasound, inaudible sound waves, which allow to "visualize" lungs.
The chest X-ray is a medical imaging examination that provides images of the lungs through the X-ray pulse.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
The sensitivity of lung ultrasound (LUS) and chest X-ray (CR) to detect community-acquired pneumonia (CAP) will be mesured and compared in patients visiting the emergency department for suspected CAP
Time Frame: Within the day of inclusion
|
Within the day of inclusion
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
specificity, positive predictive value and negative predictive value : indicators of diagnosis performance, will be measured and compared as a primary imaging for diagnosis of CAP
Time Frame: Within the day of inclusion
|
Within the day of inclusion
|
Specificity, positive predictive value, negative predictive value will be measured and compared in each sequence of imaging (CR + LUS and LUS + CR) for CAP detection
Time Frame: Within the day of inclusion
|
Within the day of inclusion
|
medical decisions for diagnosis of CAP after each step LUS then CR or CR then LUS and after low dose CT6scan (CT) will be compared to the medical decisions of the adjudication committee
Time Frame: Up to 6 months
|
Up to 6 months
|
The concordance of interpretation (for CR and CT) between attending radiologist and expert radiologist of the adjudication committee (gold standard) wil be studied.
Time Frame: Up to 6 months
|
Up to 6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: CLAESSENS Yann-Erick, MD, PhD, CH Princesse Grace
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Woodhead M. Community-acquired pneumonia in Europe: causative pathogens and resistance patterns. Eur Respir J Suppl. 2002 Jul;36:20s-27s. doi: 10.1183/09031936.02.00702002.
- Dorca J, Torres A. Lower respiratory tract infections in the community: towards a more rational approach. Eur Respir J. 1996 Aug;9(8):1588-9. doi: 10.1183/09031936.96.09081588. No abstract available.
- Claessens YE, Debray MP, Tubach F, Brun AL, Rammaert B, Hausfater P, Naccache JM, Ray P, Choquet C, Carette MF, Mayaud C, Leport C, Duval X. Early Chest Computed Tomography Scan to Assist Diagnosis and Guide Treatment Decision for Suspected Community-acquired Pneumonia. Am J Respir Crit Care Med. 2015 Oct 15;192(8):974-82. doi: 10.1164/rccm.201501-0017OC.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ANTICIPATED)
February 15, 2020
Primary Completion (ANTICIPATED)
March 1, 2020
Study Completion (ANTICIPATED)
March 1, 2020
Study Registration Dates
First Submitted
December 11, 2019
First Submitted That Met QC Criteria
December 20, 2019
First Posted (ACTUAL)
December 24, 2019
Study Record Updates
Last Update Posted (ACTUAL)
February 10, 2020
Last Update Submitted That Met QC Criteria
February 7, 2020
Last Verified
December 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 17-14
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Community-acquired Pneumonia
-
GlaxoSmithKlineTerminated
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineTerminated
-
GlaxoSmithKlineCompleted
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
University Medical Centre LjubljanaUniversity of Ljubljana, Faculty of MedicineUnknownCommunity Acquired Pneumonia | Ventilator Associated Pneumonia | Hospital Acquired PneumoniaSlovenia
-
Basilea PharmaceuticaCompletedCommunity-acquired Pneumonia (CAP) | Hospital-acquired Pneumonia (HAP)Bulgaria, Hungary, Georgia, Romania
-
Liverpool University Hospitals NHS Foundation TrustLiverpool School of Tropical MedicineCompletedCommunity Acquired Pneumonia | Lower Respiratory Tract Infection | Hospital Acquired PneumoniaUnited Kingdom
-
Future University in EgyptRecruitingCommunity-acquired PneumoniaEgypt
-
Nordsjaellands HospitalRecruitingCommunity-acquired PneumoniaDenmark
Clinical Trials on Lung Ultrasound (LUS)
-
Royal University Hospital, SaskatoonCompletedno ConditionsCanada
-
Uppsala University HospitalEnrolling by invitationUltrasonography | Thoracic SurgerySweden
-
Centre Hospitalier Universitaire de NiceUnknown
-
University Hospital, ToursNot yet recruitingRheumatoid Arthritis | Interstitial Lung Disease | Lung Ultrasound | Thoracic UltrasoundFrance
-
Rush University Medical CenterCompletedCovid19 | ARDSUnited States
-
KU LeuvenUnknownPneumonia, Viral | Pneumonia | Pregnancy Related | Pregnancy, High Risk | COVID | Diagnoses Disease | Pregnancy Complications, Infectious | Pregnancy DiseaseBelgium, Italy, United Kingdom
-
IRCCS Fondazione Stella MarisUniversity of Pisa; Ministry of Health, Italy; Fondazione C.N.R./Regione Toscana...RecruitingCerebral Palsy | Developmental Disability | Pediatric Neurological DisorderItaly
-
Icahn School of Medicine at Mount SinaiCompleted
-
University of PadovaCompleted
-
D'Or Institute for Research and EducationUniversity of Sao Paulo; Hospital Israelita Albert Einstein; Hospital Sirio-LibanesUnknownAcute Respiratory FailureBrazil